scholarly journals Depression and anxiety and their related factors in non-cystic fibrosis stable bronchiectasis

2021 ◽  
Vol 7 (2) ◽  
pp. e27-e27
Author(s):  
Ramin Sami ◽  
Mohammadali Zohal ◽  
Alireza Hajseyedjavadi ◽  
Azadeh Esmaeilian

Introduction: Bronchiectasis, as a chronic lung disease, may be associated with depression and anxiety disorders and thus decreased quality of life. Objectives: The aim of this study was to clarify the relationship of depression and anxiety with non-cystic fibrosis bronchiectasis. Patients and Methods: A total of 62 patients with non‐cystic fibrosis bronchiectasis referred to Referral University hospitals in Qazvin, Iran, were enrolled in this case-control study. The participants’ depression and anxiety levels were measured using Beck Depression Inventory and Kettle’s anxiety questionnaire, respectively. The control group was selected from healthy individuals with similar demographic characteristics to the patients. Results: Depression and anxiety were observed in 40.4% and 43.6% of patients respectively. The corresponding values were 32.8% and 32.2% in the control group. Mild anxiety had a significant relationship with bronchiectasis, since bronchiectasis increased the risk of mild anxiety by almost three times. This relationship remained significant after adjustments for gender and age (P=0.013). No significant relationships were found between bronchiectasis and the prevalence of depression. Cough severity and sputum volume had a significant correlation with anxiety in patients with bronchiectasis (R=0.374, P=0.007 and R=0.325, P=0.022 respectively). Additionally, cough severity had a significant correlation with depression (R=0.298, P=0.037). Depression and anxiety were not associated with demographic characteristics, pulmonary function test, 6-minute walk test, colonization of airways with Pseudomonas aeruginosa and CT scan findings. Conclusion: Prevalence of anxiety and depression is high in stable non‐cystic fibrosis bronchiectasis. The severity of cough and daily sputum volume are most related factors; therefore treatment of these symptoms is very important for management of psychological aspect of the disease.

Thorax ◽  
2014 ◽  
Vol 69 (12) ◽  
pp. 1090-1097 ◽  
Author(s):  
Alexandra L Quittner ◽  
Lutz Goldbeck ◽  
Janice Abbott ◽  
Alistair Duff ◽  
Patrick Lambrecht ◽  
...  

2013 ◽  
Vol 16 (2) ◽  
pp. 175-181 ◽  
Author(s):  
Mei-Yu Chang ◽  
Chin-Ho Tseng ◽  
Ya-Ling Chiou

Several studies have reported the prevalence of depression in shift nurses to be 15%, and in some cases it may even be as high as 23%. Depression is a major cause of poor sleep quality and can impede efforts to overcome the chronic fatigue that commonly affects shift nurses. Adverse mental health issues have been confirmed in shift nurses, but few studies have investigated the underlying cause of poor mental health in different shift-nurse populations. Therefore, the aim of this study was to investigate the relationship of serum trace element levels to mental health and the tendency toward depression in shift nurses. We collected blood samples from 90 shift nurses (day, evening, and night shift) who worked in intensive care units and asked them to complete a general data questionnaire as well as the Chinese version of the Beck Depression Inventory, second edition. The night-shift nurses showed mild-to-moderate depression levels, which were significantly higher than those of the control group and other shift nurses. Night-shift nurses also had higher levels of plasma copper, ferritin, interleukin (IL)-6, and alanine aminotransferase ( p < .05) than the control group and other nurses. Elevated concentrations of ferritin and IL-6 are considered important markers for the onset of depression. The results of this study suggest that plasma copper concentrations in nurses should be monitored.


PEDIATRICS ◽  
1987 ◽  
Vol 79 (2) ◽  
pp. 239-246
Author(s):  
Lynn S. Walker ◽  
Melissa B. Ford ◽  
William D. Donald

Stress and adjustment in mothers of children with cystic fibrosis was compared with that in a control group of mothers of healthy children. Mothers of children in four age groups were included: preschool, middle childhood, early adolescence, and late adolescence. Mothers of children with cystic fibrosis did not report significantly higher levels of stress than did the control group mothers; nor did they report greater feelings of inadequacy as parents. However, mothers of children with cystic fibrosis in two age groups, preschool and early adolescence, scored higher on a measure of depression than did mothers of healthy children in the same age groups. The relationship of illness severity to maternal stress and adjustment was examined in the cystic fibrosis group. The mother's subjective rating of the child's illness severity was a better indicator of her reported stress than was the Shwachman clinical rating. It appears that many mothers are able to adapt to the presence of cystic fibrosis in the family, although certain periods in the child's life and perceived increases in illness severity are associated with increased maternal distress.


Author(s):  
Benjamín Romero-Gómez ◽  
Paula Guerrero-Alonso ◽  
Juan Manuel Carmona-Torres ◽  
Blanca Notario-Pacheco ◽  
Ana Isabel Cobo-Cuenca

Background: Hypothyroidism has several symptoms (weight gain, arrhythmias, mood changes, etc.). The aims of this study were (1) to assess the prevalence of anxiety and depression in levothyroxine-treated hypothyroid women and in women without hypothyroidism; (2) to identify variables associated with anxiety and depression. Methods: A case-control study was performed with 393 women. Case-group: 153 levothyroxine-treated hypothyroid women. Control-group: 240 women without hypothyroidism. Convenience sampling. Instrument: The Hamilton Hospital Anxiety and Depression Scale (HADS), and a sociodemographic questionnaire. Results: The prevalence of anxiety in levothyroxine-treated hypothyroid women was higher than in women without hypothyroidism (29.4% vs. 16.7%, χ2 p < 0.001). The prevalence of depression in the case group was higher than in the control group (13.1% vs. 4.6%, χ2 p < 0.001). Levothyroxine-treated hypothyroid women were more likely to have anxiety (OR = 2.08, CI: 1.28–3.38) and depression (OR = 3.13, IC = 1.45–6.45). Conclusion: In spite of receiving treatment with levothyroxine, women with hypothyroidism are more likely to have depression and anxiety. Health professionals need to assess the mood of women with hypothyroidism. Although levothyroxine is a good treatment for the symptoms of hypothyroidism, it may not be enough to prevent development or persistence of depression and anxiety by itself.


2021 ◽  
Vol 12 (3) ◽  
Author(s):  
Azam Orooji ◽  
Ali Valinejadi ◽  
Maryam Hassanzad ◽  
Mohammadreza Boloursaz ◽  
Ali Akbar Velayati

Background: Patients with chronic diseases and their caregivers are at risk for mental disorders, such as depression and anxiety. Objectives: This study aimed to investigate the prevalence of depression and anxiety symptoms among cystic fibrosis (CF) patients and their parent caregivers in Iran. Methods: This descriptive-analytical cross-sectional study was carried out on 96 participants, including 60 patients and 36 parents. The Hospital Anxiety and Depression Scale was used to measure the depression and anxiety in this study. The research site was the Pediatric Respiratory Diseases Research Center of the National Research Institute of Tuberculosis and Lung Diseases in Tehran, Iran. SPSS software (version 22) was used to examine and analyze the raw data. Results: The prevalence of anxiety in patients with a mean incidence of 12.17% was higher than that in parents with a mean incidence of 11.81%. Moreover, the prevalence of depression in patients and parents (10.58%) was almost similar. In the patients’ group, there was a direct and significant relationship between the duration of diagnosis with depression and anxiety; nevertheless, there was an inverse and significant relationship between the patient’s age and anxiety. In the parents’ group, there was a significant inverse association between age and depression, as well as between the duration of diagnosis and anxiety. However, there was no significant relationship between anxiety and depression, neither in the parents’ group nor in the patients’ group. Conclusions: The high prevalence of depression and anxiety symptoms among CF patients and their parents indicates the poor mental state of these individuals, which requires planning and implementation of psychological interventions for this group.


2021 ◽  
Vol 8 (2) ◽  
pp. 85-89
Author(s):  
Mohammad Pir Hayati ◽  
Navid Eydivandi ◽  
Mehran Khodashenas ◽  
Hamid Fallah Torbeh Bar

2003 ◽  
Vol 14 (3) ◽  
pp. 155-163 ◽  
Author(s):  
Jennie Ponsford ◽  
Carlo Ziino

Abstract: Numerous outcome studies have indicated that fatigue is one of the most universal and persistent problems reported following traumatic brain injury (TBI). The present study will examine fatigue following TBI, as reported subjectively, its relationship with demographic and injury-related factors, depression and anxiety, as well as its relationship with measures of attention and mental speed. In a group of 28 TBI participants and 28 controls, TBI participants reported significantly greater fatigue on the Fatigue Severity Scale. Fatigue was greater in those who were older, more educated and a longer time post-injury. Depression was also associated with high fatigue, but not in all cases. The relationship of subjective fatigue with mental speed and attention will be the next focus of this study.


2014 ◽  
Vol 41 (5) ◽  
pp. 887-896 ◽  
Author(s):  
Emily McDonough ◽  
Renise Ayearst ◽  
Lihi Eder ◽  
Vinod Chandran ◽  
Cheryl F. Rosen ◽  
...  

Objective.(1) To determine the prevalence of depression and anxiety in patients with psoriatic arthritis (PsA) and to identify associated demographic and disease-related factors. (2) To determine whether there is a difference in the prevalence of depression and anxiety between patients with PsA and those with psoriasis without PsA (PsC).Methods.Consecutive patients attending PsA and dermatology clinics were assessed for depression and anxiety using the Hospital Anxiety and Depression Scale. Patients underwent a clinical assessment according to a standard protocol and completed questionnaires assessing their health and quality of life. T tests, ANOVA, and univariate and multivariate models were used to compare depression and anxiety prevalence between patient cohorts and to determine factors associated with depression and anxiety.Results.We assessed 306 patients with PsA and 135 with PsC. There were significantly more men in the PsA group (61.4% vs 48% with PsC) and they were more likely to be unemployed. The prevalence of both anxiety and depression was higher in patients with PsA (36.6% and 22.2%, respectively) compared to those with PsC (24.4% and 9.6%; p = 0.012, 0.002). Depression and/or anxiety were associated with unemployment, female sex, and higher actively inflamed joint count as well as disability, pain, and fatigue. In the multivariate reduced model, employment was protective for depression (OR 0.36) and a 1-unit increase on the fatigue severity scale was associated with an increased risk of depression (OR 1.5).Conclusion.The rate of depression and anxiety is significantly higher in patients with PsA than in those with PsC. Depression and anxiety are associated with disease-related factors.


Author(s):  
Luke Sy-Cherng Woon ◽  
Hatta Sidi ◽  
Nik Ruzyanei Nik Jaafar ◽  
Mohammad Farris Iman Leong Bin Abdullah

This study investigated the prevalence and severity of depression, anxiety, and stress and determined the association between various factors, social support, and depression and anxiety among university healthcare workers in Malaysia after the government lifted the movement control order (MCO) put in place to curb the coronavirus disease 2019 (COVID-19) pandemic. This online, cross-sectional survey recruited 399 participants from two university hospitals, and they were administered a self-reported questionnaire on demographic, personal, and clinical characteristics; COVID-19-related stressors; and coping. In addition, they completed the Multidimensional Scale of Perceived Social Support (MSPSS) to measure perceived social support, as well as the 21-item Depression, Anxiety, and Stress Scale (DASS-21) to assess depression, anxiety, and stress. We found that the prevalence of depression, anxiety, and stress were 21.8%, 31.6%, and 29.1%, respectively. Participants with moderate to extremely severe depression, anxiety, and stress made up 13.3%, 25.8%, and 8.1% of the sample, respectively. Being single or divorced, fear of frequent exposure to COVID-19 patients, those who agreed that their area of living had a high prevalence of COVID-19 cases, and uncertainty regarding the prevalence of COVID-19 cases in the area of living were associated with higher odds of depression and anxiety. Conversely, having more than three children and greater perceived friend support were associated with lower odds of depression and anxiety. The prevalence of depression, anxiety, and stress remained elevated even after the MCO was lifted.


Sign in / Sign up

Export Citation Format

Share Document